Abdollah Ardebili
Overview
Explore the profile of Abdollah Ardebili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1033
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eiri A, Kaboosi H, Niknejad F, Ardebili A, Joshaghani H
Folia Microbiol (Praha)
. 2024 Dec;
PMID: 39739220
The contamination of food and animal feeds with mycotoxions, particularly aflatoxin B1 (AFB1), poses significant risks to human health and causes economic losses. This study investigated bacteria from various fermented...
2.
Zolpirani F, Ghaemi E, Yasaghi M, Nikokar I, Ardebili A
Braz J Microbiol
. 2024 Jun;
55(3):2715-2726.
PMID: 38926315
Pseudomonas aeruginosa is one of the most important nosocomial pathogens that possess the ability to produce multiple antibiotic resistance and virulence factors. Elastase B (LasB) is the major factor implicated...
3.
Najari E, Zamani S, Sheikh Arabi M, Ardebili A
J Infect Chemother
. 2024 Mar;
30(9):892-898.
PMID: 38432556
Introduction: Development of multi-, extensively-, and pandrug-resistant (MDR, XDR, and PDR) strains of Pseudomonas aeruginosa remains a major problem in medical care. The present study evaluated the effect of antimicrobial...
4.
Sharafi T, Ghaemi E, Rafiee M, Ardebili A
Ann Clin Microbiol Antimicrob
. 2024 Jan;
23(1):7.
PMID: 38245727
The ability of Staphylococcus epidermidis and S. aureus to form strong biofilm on plastic devices makes them the major pathogens associated with device-related infections (DRIs). Biofilm-embedded bacteria are more resistant...
5.
Ardebili A, Izanloo A, Rastegar M
Expert Rev Anti Infect Ther
. 2023 Feb;
21(4):387-429.
PMID: 36820511
Introduction: The increasing prevalence of infections with multidrug-resistant (MDR), extensively-drug resistant (XDR) or difficult-to-treat drug resistant (DTR) Gram-negative bacilli (GNB), including Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Enterobacter species, and...
6.
Shahri F, Izanloo A, Goharrizi M, Jamali A, Bagheri H, Hjimohammadi A, et al.
Int Microbiol
. 2022 Jun;
25(4):709-721.
PMID: 35697891
Pseudomonas aeruginosa is an important nosocomial pathogen with a capacity of resistance to multiple antibiotics and production of various extracellular and cell-associated virulence factors that clearly contribute to its pathogenicity....
7.
Kamali E, Jamali A, Izanloo A, Ardebili A
BMC Microbiol
. 2021 Dec;
21(1):347.
PMID: 34915848
Background: Biofilms are a main pathogenicity feature of Pseudomonas aeruginosa and has a significant role in antibiotic resistance and persistent infections in humans. We investigated the in vitro activities of...
8.
Ardebili A, Pouriayevali M, Aleshikh S, Zahani M, Ajorloo M, Izanloo A, et al.
Molecules
. 2021 Nov;
26(22).
PMID: 34834089
The treatment of viral disease has become a medical challenge because of the increasing incidence and prevalence of human viral pathogens, as well as the lack of viable treatment alternatives,...
9.
Davoudabadi S, Goudarzi H, Goudarzi M, Ardebili A, Faghihloo E, Sharahi J, et al.
Acta Microbiol Immunol Hung
. 2021 Sep;
PMID: 34546968
In this study, we focused on the emergence of extensively drug-resistant (XDR), pandrug-resistant (PDR), and hypervirulent Klebsiella pneumoniae (hvKP) in Iran. During 2018 to 2020 a total of 52 K....
10.
Rad Z, Rad Z, Goudarzi H, Goudarzi M, Alizade H, Mazraeh F, et al.
Acta Microbiol Immunol Hung
. 2021 May;
PMID: 33974553
Carbapenems are employed to treat infections caused by Gram-negative bacteria including Klebsiella pneumoniae. This research is aimed to perform phenotypic detection of β-lactamases and molecular characterization of NDM-1 positive K....